HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Critical role of retinoid/rexinoid signaling in mediating transformation and therapeutic response of NUP98-RARG leukemia.

Abstract
While the nucleoporin 98-retinoic acid receptor gamma (NUP98-RARG) is the first RARG fusion protein found in acute leukemia, its roles and the molecular basis in oncogenic transformation are currently unknown. Here, we showed that homodimeric NUP98-RARG not only acquired unique nuclear localization pattern and ability of recruiting both RXRA and wild-type NUP98, but also exhibited similar transcriptional properties as RARA fusions found in acute promyelocytic leukemia (APL). Using murine bone marrow retroviral transduction/transformation assay, we further demonstrated that NUP98-RARG fusion protein had gained transformation ability of primary hematopoietic stem/progenitor cells, which was critically dependent on the C-terminal GLFG domain of NUP98 and the DNA binding domain (DBD) of RARG. In contrast to other NUP98 fusions, cells transformed by the NUP98-RARG fusion were extremely sensitive to all-trans retinoic acid (ATRA) treatment. Interestingly, while pan-RXR agonists, SR11237 and LGD1069 could specifically inhibit NUP98-RARG transformed cells, mutation of the RXR interaction domain in NUP98-RARG had little effect on its transformation, revealing that therapeutic functions of rexinoid can be independent of the direct biochemical interaction between RXR and the fusion. Together, these results indicate that deregulation of the retinoid/rexinoid signaling pathway has a major role and may represent a potential therapeutic target for NUP98-RARG-mediated transformation.
AuthorsJ J Qiu, B B Zeisig, S Li, W Liu, H Chu, Y Song, A Giordano, J Schwaller, H Gronemeyer, S Dong, C W E So
JournalLeukemia (Leukemia) Vol. 29 Issue 5 Pg. 1153-62 (May 2015) ISSN: 1476-5551 [Electronic] England
PMID25510432 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Nuclear Pore Complex Proteins
  • Receptors, Retinoic Acid
  • Recombinant Fusion Proteins
  • nuclear pore complex protein 98
  • retinoic acid receptor gamma
  • Tretinoin
Topics
  • Animals
  • Cell Nucleus (metabolism)
  • Cell Transformation, Neoplastic
  • Gene Expression Regulation, Leukemic
  • HEK293 Cells
  • HeLa Cells
  • Humans
  • Leukemia (metabolism)
  • Mice
  • Microscopy, Fluorescence
  • Nuclear Pore Complex Proteins (metabolism)
  • Protein Binding
  • Protein Interaction Mapping
  • Protein Multimerization
  • Protein Structure, Tertiary
  • Receptors, Retinoic Acid (metabolism)
  • Recombinant Fusion Proteins (metabolism)
  • Retroviridae (genetics)
  • Signal Transduction
  • Tretinoin (chemistry)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: